1. Risk of malignancy in resected pancreatic mucinous cystic neoplasms
- Author
-
Stuart Robinson, G.O. Ceyhan, Anne Antila, Yrjö Vaalavuo, Stephen P. Pereira, C. Verdejo Gil, Margaret G. Keane, Linda N. Nilsson, Johanna Laukkarinen, Awad Shamali, M. Marijinissen Van Zanten, Patrick Maisonneuve, M. Abu Hilal, J. Millastre Bocos, M Del Chiaro, and T. Hoskins
- Subjects
Adult ,Male ,Risk ,medicine.medical_specialty ,Adolescent ,medicine.medical_treatment ,Pancreatic mucinous cystic neoplasm ,Cystadenocarcinoma, Mucinous ,Malignancy ,Gastroenterology ,Preoperative care ,Young Adult ,03 medical and health sciences ,Pancreatectomy ,0302 clinical medicine ,Internal medicine ,medicine ,Humans ,Cystadenocarcinoma ,Aged ,Retrospective Studies ,Aged, 80 and over ,business.industry ,Retrospective cohort study ,Odds ratio ,Middle Aged ,medicine.disease ,Pancreatic Neoplasms ,Dysplasia ,030220 oncology & carcinogenesis ,Female ,030211 gastroenterology & hepatology ,Surgery ,business ,Follow-Up Studies - Abstract
Background Pancreatic mucinous cystic neoplasms (MCNs) are rare mucin-producing cystic tumours defined by the presence of ovarian-type stroma. MCNs have a malignant potential and thus surgery is frequently performed. The aim of this cohort study was to define better the criteria for surgical resection in patients with MCN. Methods This multicentre retrospective study included all resected MCNs between 2003 and 2015 in participating centres. Lesions without ovarian-type stroma were excluded. Patient characteristics, preoperative findings, histopathology findings and follow-up data were recorded. Results The study included 211 patients; their median age was 53 (range 18–82) years, and 202 (95·7 per cent) were women. Median preoperative tumour size was 55 (range 12–230) mm. Thirty-four of the 211 (16·1 per cent) were malignant, and high-grade dysplasia (HGD) was found in a further 13 (6·2 per cent). One-third of MCNs in men were associated with invasive cancer, compared with 15·3 per cent in women. Five cases of malignant transformation occurred in MCNs smaller than 4 cm. All cases of malignancy or HGD were associated with symptoms or features of concern on preoperative cross-sectional imaging. In multivariable analysis, raised carbohydrate antigen 19-9 (odds ratio (OR) 10·54, 95 per cent c.i. 2·85 to 218·23; P < 0·001), tumour size (OR 4·23, 3·02 to 11·03; P = 0·001), mural nodules (OR 3·55, 1·31 to 20·55; P = 0·002) and weight loss (OR 3·40, 2·34 to 12·34; P = 0·034) were independent factors predictive of malignant transformation. Conclusions Small indeterminate MCNs with no symptoms or features of concern may safely be observed as they have a low risk of malignant transformation.
- Published
- 2018
- Full Text
- View/download PDF